On April 26, 2018 Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reported that first quarter 2018 financial results will be released on Thursday, May 3, 2018 before the market opens (Press release, Cambrex, APR 26, 2018, View Source [SID1234525733]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

First Quarter 2018 Earnings Conference Call
When: Thursday, May 3, 2018 at 8:30 a.m. Eastern Time
Dial-in: 1-877-260-1479 for U
1-334-323-0522 for International
Passcode: 5093025
Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Passcode: 5093025
Available through Thursday, May 10, 2018
Webcast: www.cambrex.com